Wednesday, November 11, 2026

DRAM Prices Forecast to Double in 2026 as AI Memory Demand Outpaces Supply

DRAM prices are forecast to surge 125% for full-year 2026, with a 58-63% jump expected in Q2 alone. Micron shares are already up 162% year-to-date, signaling market conviction that memory constraints will define AI infrastructure costs through H2 2026. Cloud AI providers and compute-heavy startups face direct margin pressure.

LM Salvado

May 12, 2026

DRAM Prices Forecast to Double in 2026 as AI Memory Demand Outpaces Supply
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...
1

The driver is structural. AI model training and inference are hitting memory capacity limits. As model sizes grow and inference deployments scale across millions of requests, memory — not compute — is becoming the binding constraint on infrastructure expansion.

Cloud AI providers and AI startups face a direct cost problem. Memory hardware represents a large share of GPU server bills. A full-year price increase of this scale translates to materially higher infrastructure capex in H2 2026.1 Startups burning capital on inference workloads face compressed runways. AI SaaS companies with heavy compute costs may miss earnings estimates as hardware expenses accelerate faster than revenue growth.1

The supply side tells a different story. Memory semiconductor suppliers are positioned to benefit directly. Micron and SK Hynix are expected to outperform as prices climb.1 Both supply the high-bandwidth and standard DRAM configurations used in AI server deployments.

This creates a divergence in AI economics. Companies that lock in supply contracts or vertically integrate memory procurement gain a durable cost advantage. Those buying at spot prices through H2 2026 absorb the full impact of the surge.

The broader AI infrastructure buildout — data centers, networking, power capacity — has dominated capital allocation discussions. Memory pricing signals that the next hardware constraint is more specific: DRAM and high-bandwidth memory availability at scale.

For AI companies planning capacity through the rest of 2026, memory procurement is no longer a procurement line item. It is a strategic variable that will determine which providers can scale inference profitably and which cannot.

About this analysis

This is a Via News analysis. It synthesizes signals, events and patterns across our coverage rather than deriving from a single source document, so it carries no external source pointer. Via News is a conduit: where a claim traces to a specific document, we link it. How we source

LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com